BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Medical Carbon Research Institute Release: FDA Approved Non-Warfarin And Reduced Warfarin Anticoagulation Trial Of The On-X Prosthetic Heart Valve Initiated At Emory Crawford Long Hospital


8/22/2006 11:29:48 AM

AUSTIN, Texas--(BUSINESS WIRE)--Aug. 22, 2006-- Medical Carbon Research Institute L.L.C. (MCRI(TM)) today announced initiation of the FDA approved clinical trial PROACT (Prospective Randomized On-X(R) Prosthetic Heart Valve Anticoagulation Clinical Trial) being conducted under an investigational device exemption (IDE) at reduced anticoagulation levels at Emory Crawford Long Hospital, Emory University in Atlanta, Georgia. The study began with the approval of the Crawford Long and Emory University Institutional Review Board and the first implantation of the On-X valve under the approved protocol and is also being conducted at 19 other prestigious institutions throughout the US. Successful completion of the clinical study could result in the On-X valve becoming the only mechanical heart valve approved for low-dose anticoagulation therapy.

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES